Cargando…
An In-silico Screening Strategy to the Prediction of New Inhibitors of COVID-19 M(pro) Protein
The coronavirus disease-2019 (COVID-19) was first recognized in Wuhan, China, and quickly spread worldwide. Between all proposed research guidelines, inhibition of the main protease (M(pro)) protein of the virus will be one of the main strategies for COVID-19 treatment. The present work was aimed to...
Autores principales: | Abbasi, Maryam, Sadeghi-aliabadi, Hojjat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842622/ https://www.ncbi.nlm.nih.gov/pubmed/35194434 http://dx.doi.org/10.22037/ijpr.2021.114997.15146 |
Ejemplares similares
-
Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation
por: Abbasi, Maryam, et al.
Publicado: (2017) -
A study on quantitative structure–activity relationship and molecular docking of metalloproteinase inhibitors based on L-tyrosine scaffold
por: Abbasi, Maryam, et al.
Publicado: (2015) -
Theoretical design of a new chimeric protein for the treatment of breast cancer
por: Soleimani, Meysam, et al.
Publicado: (2016) -
Non-covalent SARS-CoV-2 M(pro) inhibitors developed from in silico screen hits
por: Rossetti, Giacomo G., et al.
Publicado: (2022) -
Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain
por: Sadeghi-Aliabadi, Hojjat, et al.
Publicado: (2014)